Journal of the American College of Certified Wound Specialists
Volume 1, Issue 3 , Pages 86-91, July 2009

Impaired Lower Extremity Wound Healing Secondary to Sirolimus After Kidney Transplantation

  • J. George DeVries, DPM

      Affiliations

    • A PGY-2 Resident; Wheaton Fransciscan Healthcare, Milwaukee, WI
  • ,
  • Rachel C. Collier

      Affiliations

    • Podiatry student extern; Wheaton Fransciscan Healthcare, Milwaukee, WI
    • Corresponding Author InformationCorresponding author.
  • ,
  • Jeffrey A. Niezgoda, MD, FACEEP, FACHM

      Affiliations

    • President, Hyperbaric and Wound Care Associates, Milwaukee, WI
  • ,
  • Shawn Sanicola, DPM

      Affiliations

    • Attending Staff, Wheaton Franciscan Healthcare, Milwaukee, WI
  • ,
  • John P. Simanonok, MD

      Affiliations

    • E Staff, Hyperbaric and Wound Care Associates, Milwaukee, WI

Abstract 

Purpose

Sirolimus is an immunosuppressive drug used as part of the drug regimen after kidney, liver, and heart transplantation. There have been numerous reports of transplant surgical wound healing complications secondary to sirolimus. The authors present a case of impaired wound healing in the lower extremity after kidney transplantation for a patient on sirolimus. This is one of the few reported cases that we are aware of that demonstrates the effects of sirolimus on wound healing at a nontransplant site.

Methods

A case highlighting aggressive limb-salvage modalities for a kidney transplant patient on sirolimus is presented. The subject was informed that data concerning the case would be submitted for publication. A brief review of the literature shows the wound healing problems previously associated with sirolimus.

Results

Despite all salvage techniques employed, including aggressive early debridement, forefoot offloading, IV antibiotics, negative pressure wound therapy, and hyperbaric oxygen therapy, the patient eventually went on to failure and a transtibial amputation.

Conclusion

Physicians specializing in wound care and limb salvage must be aware of the effects of sirolimus on wound healing and should consider modifications to these patients' immunosuppressive regimens.

Keywords: Sirolimus, Diabetes, Wound, Immunosuppression, Transplant, Introduction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1876-4983(09)00086-1

doi:10.1016/j.jcws.2009.06.001

Journal of the American College of Certified Wound Specialists
Volume 1, Issue 3 , Pages 86-91, July 2009